A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy
Clinical trial NCT06286046 · WITHDRAWN
Trial details
- NCT number
- NCT06286046
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-05-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.